Breaking News Instant updates and real-time market news.

EW

Edwards Lifesciences

$72.01 /

-14.27 (-16.54%)

12:00
10/28/22
10/28
12:00
10/28/22
12:00

Edwards Lifesciences falls -16.6%

Edwards Lifesciences is down -16.6%, or -$14.31 to $71.99.

OTHER BREAKING NEWS FROM THE FLY

Hot Stocks
Olink technology enables further development of South African research » 08:18
03/29/23
03/29
08:18
03/29/23
08:18
OLK

Olink

$19.83 /

-1.8 (-8.32%)

Olink announced that the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
OLK Olink
$19.83 /

-1.8 (-8.32%)

OLK Olink
$19.83 /

-1.8 (-8.32%)

01/05/23 Scotiabank
Olink initiated with an Outperform at Scotiabank
01/04/23 Scotiabank
Olink initiated with an Outperform at Scotiabank
12/14/22 Canaccord
Olink initiated with a Buy at Canaccord
OLK Olink
$19.83 /

-1.8 (-8.32%)

  • 19
    Jan
OLK Olink
$19.83 /

-1.8 (-8.32%)

Hot Stocks
Verses, SimWell partner to enhance digital twin stimulations with KOSMOS » 08:17
03/29/23
03/29
08:17
03/29/23
08:17
VRSSF

Verses Technologies

/

+

VERSES Technologies…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VRSSF Verses Technologies
/

+

Hot Stocks
Crispr Therapeutics announces departure of board member » 08:16
03/29/23
03/29
08:16
03/29/23
08:16
CRSP

Crispr Therapeutics

$43.84 /

-0.49 (-1.11%)

CRISPR Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CRSP Crispr Therapeutics
$43.84 /

-0.49 (-1.11%)

CRSP Crispr Therapeutics
$43.84 /

-0.49 (-1.11%)

03/21/23 Bernstein
Crispr Therapeutics initiated with a Market Perform at Bernstein
03/18/23 Citi
Crispr Therapeutics price target lowered to $55 from $63 at Citi
03/17/23 Bryan Garnier
Crispr Therapeutics initiated with a Buy at Bryan Garnier
03/06/23 Baird
Baird starts Crispr at Neutral with strong launch priced in
CRSP Crispr Therapeutics
$43.84 /

-0.49 (-1.11%)

CRSP Crispr Therapeutics
$43.84 /

-0.49 (-1.11%)

Hot Stocks
G Medical Innovations enters into agreement with AdventHealth Central Florida » 08:15
03/29/23
03/29
08:15
03/29/23
08:15
GMVD

G Medical Innovations

$1.89 /

-0.05 (-2.58%)

G Medical Innovations…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GMVD G Medical Innovations
$1.89 /

-0.05 (-2.58%)

Hot Stocks
Caribou initiates dose expansion portion of CB-010 ANTLER Phase 1 trial » 08:15
03/29/23
03/29
08:15
03/29/23
08:15
CRBU

Caribou Biosciences

$4.71 /

+0.02 (+0.43%)

Caribou Biosciences…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CRBU Caribou Biosciences
$4.71 /

+0.02 (+0.43%)

CRBU Caribou Biosciences
$4.71 /

+0.02 (+0.43%)

03/18/23 BofA
Caribou Biosciences price target lowered to $25 from $27 at BofA
03/14/23 H.C. Wainwright
Caribou Biosciences price target lowered to $26 from $27 at H.C. Wainwright
03/10/23 Oppenheimer
Caribou Biosciences price target lowered to $32 from $36 at Oppenheimer
11/23/22 Citi
Caribou Biosciences price target lowered to $37 from $38 at Citi
CRBU Caribou Biosciences
$4.71 /

+0.02 (+0.43%)

Hot Stocks
First Solar announces facility in India awarded financial incentives » 08:13
03/29/23
03/29
08:13
03/29/23
08:13
FSLR

First Solar

$210.01 /

+0.08 (+0.04%)

First Solar announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FSLR First Solar
$210.01 /

+0.08 (+0.04%)

FSLR First Solar
$210.01 /

+0.08 (+0.04%)

03/23/23 Barclays
First Solar price target raised to $230 from $162 at Barclays
03/15/23 Credit Suisse
First Solar price target raised to $163 from $152 at Credit Suisse
03/14/23 Argus
First Solar price target raised to $261 from $176 at Argus
03/09/23 Citi
First Solar transferred with Neutral rating at Citi
FSLR First Solar
$210.01 /

+0.08 (+0.04%)

FSLR First Solar
$210.01 /

+0.08 (+0.04%)

FSLR First Solar
$210.01 /

+0.08 (+0.04%)

FSLR First Solar
$210.01 /

+0.08 (+0.04%)

Hot Stocks
Caribou Biosciences doses first patient in CaMMouflage Phase 1 trial of CB-011 » 08:12
03/29/23
03/29
08:12
03/29/23
08:12
CRBU

Caribou Biosciences

$4.71 /

+0.02 (+0.43%)

Caribou Biosciences…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CRBU Caribou Biosciences
$4.71 /

+0.02 (+0.43%)

CRBU Caribou Biosciences
$4.71 /

+0.02 (+0.43%)

03/18/23 BofA
Caribou Biosciences price target lowered to $25 from $27 at BofA
03/14/23 H.C. Wainwright
Caribou Biosciences price target lowered to $26 from $27 at H.C. Wainwright
03/10/23 Oppenheimer
Caribou Biosciences price target lowered to $32 from $36 at Oppenheimer
11/23/22 Citi
Caribou Biosciences price target lowered to $37 from $38 at Citi
CRBU Caribou Biosciences
$4.71 /

+0.02 (+0.43%)

Recommendations
Viking Therapeutics price target raised to $25 from $15 at Maxim » 08:12
03/29/23
03/29
08:12
03/29/23
08:12
VKTX

Viking Therapeutics

$15.41 /

+6.28 (+68.78%)

Maxim raised the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VKTX Viking Therapeutics
$15.41 /

+6.28 (+68.78%)

VKTX Viking Therapeutics
$15.41 /

+6.28 (+68.78%)

06:15 Today Raymond James
Viking Therapeutics price target raised to $35 from $12 at Raymond James
03/28/23 BTIG
Viking Therapeutics price target raised to $31 from $20 at BTIG
03/28/23 Oppenheimer
Viking Therapeutics price target raised to $30 from $20 at Oppenheimer
03/28/23 Stifel
Stifel reiterates Buy on Viking Therapeutics, raises price target to $25
VKTX Viking Therapeutics
$15.41 /

+6.28 (+68.78%)

VKTX Viking Therapeutics
$15.41 /

+6.28 (+68.78%)

VKTX Viking Therapeutics
$15.41 /

+6.28 (+68.78%)

VKTX Viking Therapeutics
$15.41 /

+6.28 (+68.78%)

Hot Stocks
Enphase Energy launches new IQ8 microinverters in France, the Netherlands » 08:12
03/29/23
03/29
08:12
03/29/23
08:12
ENPH

Enphase Energy

$193.50 /

-2.28 (-1.16%)

Enphase Energy announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ENPH Enphase Energy
$193.50 /

-2.28 (-1.16%)

ENPH Enphase Energy
$193.50 /

-2.28 (-1.16%)

03/22/23 Susquehanna
Enphase upgraded to Positive on recent pullback at Susquehanna
03/22/23 Susquehanna
Enphase Energy upgraded to Positive from Neutral at Susquehanna
03/20/23 Raymond James
Enphase Energy upgraded to Outperform from Market Perform at Raymond James
03/09/23 Citi
Enphase Energy transferred with Buy rating at Citi
ENPH Enphase Energy
$193.50 /

-2.28 (-1.16%)

ENPH Enphase Energy
$193.50 /

-2.28 (-1.16%)

ENPH Enphase Energy
$193.50 /

-2.28 (-1.16%)

ENPH Enphase Energy
$193.50 /

-2.28 (-1.16%)

Hot Stocks
Akari announces Poland, U.K. approve new manufacturing process for nomacopan » 08:10
03/29/23
03/29
08:10
03/29/23
08:10
AKTX

Akari Therapeutics

/

+

Akari Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AKTX Akari Therapeutics
/

+

AKTX Akari Therapeutics
/

+

12/05/22 H.C. Wainwright
Akari Therapeutics initiated with a Buy at H.C. Wainwright
11/01/22 Alliance Global Partners
Akari Therapeutics initiated with a Buy at Alliance Global Partners
Upgrade
Anhui Conch Cement upgraded to Neutral from Sell at Goldman Sachs » 08:10
03/29/23
03/29
08:10
03/29/23
08:10
AHCHY

Anhui Conch Cement

$17.45 /

+0.26 (+1.51%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AHCHY Anhui Conch Cement
$17.45 /

+0.26 (+1.51%)

11/15/22 HSBC
Anhui Conch Cement upgraded to Buy from Hold at HSBC
08/28/22 Goldman Sachs
Anhui Conch Cement downgraded to Sell from Neutral at Goldman Sachs
Hot Stocks
Kala Pharmaceuticals appoints Francis Mah as chief medical advisor » 08:10
03/29/23
03/29
08:10
03/29/23
08:10
KALA

Kala Pharmaceuticals

$15.59 /

+0.59 (+3.93%)

Kala Pharmaceuticals…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
KALA Kala Pharmaceuticals
$15.59 /

+0.59 (+3.93%)

KALA Kala Pharmaceuticals
$15.59 /

+0.59 (+3.93%)

03/06/23 H.C. Wainwright
Kala Pharmaceuticals price target raised to $20 from $12 at H.C. Wainwright
12/29/22 Wedbush
IND acceptance sets up Kala for execution year in 2023, says Wedbush
11/09/22 Wedbush
Kala Pharmaceuticals price target raised to $47 from $3 at Wedbush
05/24/22 H.C. Wainwright
Kala Pharmaceuticals price target lowered to $4 from $5 at H.C. Wainwright
KALA Kala Pharmaceuticals
$15.59 /

+0.59 (+3.93%)

KALA Kala Pharmaceuticals
$15.59 /

+0.59 (+3.93%)

Hot Stocks
NV5 awarded $11M essential infrastructure projects in California, New Mexico » 08:09
03/29/23
03/29
08:09
03/29/23
08:09
NVEE

NV5 Global

$100.90 /

+0.02 (+0.02%)

NV5 Global announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NVEE NV5 Global
$100.90 /

+0.02 (+0.02%)

NVEE NV5 Global
$100.90 /

+0.02 (+0.02%)

02/24/23 Baird
NV5 Global price target lowered to $130 from $150 at Baird
08/05/22 Lake Street
NV5 Global price target raised to $175 from $136 at Lake Street
NVEE NV5 Global
$100.90 /

+0.02 (+0.02%)

Hot Stocks
DoubleDown announces results of 2023 Annual General Meeting » 08:09
03/29/23
03/29
08:09
03/29/23
08:09
DDI

DoubleDown

$8.09 /

+0.08 (+1.00%)

DoubleDown Interactive…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DDI DoubleDown
$8.09 /

+0.08 (+1.00%)

DDI DoubleDown
$8.09 /

+0.08 (+1.00%)

09/15/22 Macquarie
DoubleDown initiated with an Outperform at Macquarie
07/11/22 B. Riley
Investors have overlooked DoubleDown, says B. Riley
06/28/22 B. Riley
DoubleDown price target lowered to $20 from $30 at B. Riley
Initiation
Engie Brasil initiated with an Outperform at Scotiabank » 08:09
03/29/23
03/29
08:09
03/29/23
08:09
EGIEY

Engie Brasil

$8.00 /

+0.34 (+4.44%)

Scotiabank analyst Renato…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
EGIEY Engie Brasil
$8.00 /

+0.34 (+4.44%)

03/07/23 UBS
Engie Brasil upgraded to Buy from Neutral at UBS
01/10/23 JPMorgan
Engie Brasil upgraded to Overweight from Neutral at JPMorgan
10/14/22 JPMorgan
Engie Brasil upgraded to Neutral from Underweight at JPMorgan
08/08/22 JPMorgan
Engie Brasil downgraded to Underweight from Neutral at JPMorgan
Recommendations
LuxUrban Hotels price target raised to $7 from $6 at Maxim » 08:08
03/29/23
03/29
08:08
03/29/23
08:08
LUXH

LuxUrban Hotels

$2.31 /

-0.12 (-4.95%)

Maxim raised the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LUXH LuxUrban Hotels
$2.31 /

-0.12 (-4.95%)

LUXH LuxUrban Hotels
$2.31 /

-0.12 (-4.95%)

12/12/22 Maxim
LuxUrban Hotels initiated with a Buy at Maxim
LUXH LuxUrban Hotels
$2.31 /

-0.12 (-4.95%)

Hot Stocks
Rapt Therapeutics announces initiation of Phase 2a trial of RPT193 » 08:08
03/29/23
03/29
08:08
03/29/23
08:08
RAPT

Rapt Therapeutics

$17.86 /

+0.02 (+0.11%)

RAPT Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RAPT Rapt Therapeutics
$17.86 /

+0.02 (+0.11%)

RAPT Rapt Therapeutics
$17.86 /

+0.02 (+0.11%)

03/15/23 Capital One
Rapt outlook 'remains steady' despite shift in timeline, says Capital One
03/15/23 Cantor Fitzgerald
Rapt Therapeutics price target lowered to $40 from $44 at Cantor Fitzgerald
03/15/23 H.C. Wainwright
Rapt Therapeutics price target lowered to $43 from $50 at H.C. Wainwright
01/04/23 Guggenheim
Rapt Therapeutics initiated with a Buy at Guggenheim
RAPT Rapt Therapeutics
$17.86 /

+0.02 (+0.11%)

  • 18
    Nov
RAPT Rapt Therapeutics
$17.86 /

+0.02 (+0.11%)

Hot Stocks
Harmony Biosciences reports accelerated timeline for Phase 3 hypersomnia study » 08:08
03/29/23
03/29
08:08
03/29/23
08:08
HRMY

Harmony Biosciences

$30.81 /

-10.69 (-25.76%)

Harmony Biosciences…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
HRMY Harmony Biosciences
$30.81 /

-10.69 (-25.76%)

HRMY Harmony Biosciences
$30.81 /

-10.69 (-25.76%)

03/28/23 Mizuho
Harmony short report 'misleading,' 'perhaps even sensational,' says Mizuho
03/28/23 Raymond James
Raymond James says buy Harmony on weakness after 'low quality' short report
02/22/23 Mizuho
Harmony Biosciences price target lowered to $60 from $70 at Mizuho
01/04/23 Piper Sandler
Harmony Biosciences price target raised to $70 from $62 at Piper Sandler
HRMY Harmony Biosciences
$30.81 /

-10.69 (-25.76%)

HRMY Harmony Biosciences
$30.81 /

-10.69 (-25.76%)

HRMY Harmony Biosciences
$30.81 /

-10.69 (-25.76%)

Hot Stocks
Pacira announces FDA clearance of sNDA for EXPAREL label » 08:07
03/29/23
03/29
08:07
03/29/23
08:07
PCRX

Pacira

$39.93 /

-0.15 (-0.37%)

Pacira BioSciences…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PCRX Pacira
$39.93 /

-0.15 (-0.37%)

PCRX Pacira
$39.93 /

-0.15 (-0.37%)

03/03/23 Barclays
Pacira price target lowered to $80 from $90 at Barclays
03/01/23 H.C. Wainwright
Pacira price target raised to $71 from $69 at H.C. Wainwright
02/10/23 H.C. Wainwright
Pacira price target lowered to $69 from $76 at H.C. Wainwright
01/31/23 Wedbush
Pacira assumed with an Outperform at Wedbush
PCRX Pacira
$39.93 /

-0.15 (-0.37%)

Hot Stocks
Baltimore Orioles select Shift4 to process payments for ballpark concessions » 08:07
03/29/23
03/29
08:07
03/29/23
08:07
FOUR

Shift4 Payments

$68.98 /

+1.9 (+2.83%)

"We're thrilled…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FOUR Shift4 Payments
$68.98 /

+1.9 (+2.83%)

FOUR Shift4 Payments
$68.98 /

+1.9 (+2.83%)

03/16/23 Truist
Shift4 Payments price target raised to $87 from $80 at Truist
03/01/23 RBC Capital
Shift4 Payments price target raised to $80 from $70 at RBC Capital
03/01/23 Piper Sandler
Shift4 Payments price target raised to $85 from $69 at Piper Sandler
03/01/23 DA Davidson
Shift4 Payments price target raised to $80 from $65 at DA Davidson
FOUR Shift4 Payments
$68.98 /

+1.9 (+2.83%)

FOUR Shift4 Payments
$68.98 /

+1.9 (+2.83%)

FOUR Shift4 Payments
$68.98 /

+1.9 (+2.83%)

Hot Stocks
Precigen: First patient dosed in Phase 1/1b study of of PRGN-3007 » 08:07
03/29/23
03/29
08:07
03/29/23
08:07
PGEN

Precigen

/

+

Precigen announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PGEN Precigen
/

+

PGEN Precigen
/

+

01/30/23 Cantor Fitzgerald
Precigen price target raised to $10 from $7 at Cantor Fitzgerald
12/28/22 Cantor Fitzgerald
Cantor calls Merck top large cap pharma pick, names 8 SMID cap top picks
11/18/22 Cantor Fitzgerald
Precigen initiated with an Overweight at Cantor Fitzgerald
11/18/22 Cantor Fitzgerald
Precigen initiated with an Overweight at Cantor Fitzgerald
PGEN Precigen
/

+

  • 25
    Jan
PGEN Precigen
/

+

PGEN Precigen
/

+

Hot Stocks
Third Harmonic Bio expects cash to fund requirements through next 12 months » 08:06
03/29/23
03/29
08:06
03/29/23
08:06
THRD

Third Harmonic Bio

$4.30 /

+0.02 (+0.47%)

Cash and cash equivalents…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
THRD Third Harmonic Bio
$4.30 /

+0.02 (+0.47%)

THRD Third Harmonic Bio
$4.30 /

+0.02 (+0.47%)

12/16/22 Jefferies
Third Harmonic Bio downgraded to Hold from Buy at Jefferies
12/16/22 LifeSci Capital
Third Harmonic Bio downgraded to Market Perform at LifeSci Capital
12/15/22 Morgan Stanley
Morgan Stanley downgrades Third Harmonic after 'disappointing' discontinuation
12/15/22 Morgan Stanley
Third Harmonic Bio downgraded to Equal Weight from Overweight at Morgan Stanley
THRD Third Harmonic Bio
$4.30 /

+0.02 (+0.47%)

  • 15
    Sep
THRD Third Harmonic Bio
$4.30 /

+0.02 (+0.47%)

Recommendations
Biolase price target lowered to $1 from $5 at Maxim » 08:06
03/29/23
03/29
08:06
03/29/23
08:06
BIOL

Biolase

/

+

Maxim analyst Anthony…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BIOL Biolase
/

+

BIOL Biolase
/

+

01/20/23 Lake Street
Biolase assumed with a Buy at Lake Street
11/11/22 Maxim
Biolase price target lowered to $5 from $10 at Maxim
05/20/22 Lake Street
Biolase initiated with a Buy at Lake Street
BIOL Biolase
/

+

Hot Stocks
ProQR announces initial pipeline targets, highlights Axiomer platfotform » 08:06
03/29/23
03/29
08:06
03/29/23
08:06
PRQR

ProQR Therapeutics

$3.58 /

-0.02 (-0.56%)

ProQR Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PRQR ProQR Therapeutics
$3.58 /

-0.02 (-0.56%)

PRQR ProQR Therapeutics
$3.58 /

-0.02 (-0.56%)

03/10/23 Stifel
Stifel says SVB fallout 'appears limited' across firm's biotech coverage
12/28/22 Cantor Fitzgerald
Cantor calls Merck top large cap pharma pick, names 8 SMID cap top picks
12/23/22 Raymond James
ProQR Therapeutics price target raised to $5 from $2 at Raymond James
12/22/22 JMP Securities
ProQR Therapeutics shares remain 'fairly valued,' says JMP Securities
PRQR ProQR Therapeutics
$3.58 /

-0.02 (-0.56%)

PRQR ProQR Therapeutics
$3.58 /

-0.02 (-0.56%)

Hot Stocks
EzFill and SaverOne 2014 launch driving safety pilot program in Florida » 08:06
03/29/23
03/29
08:06
03/29/23
08:06
SVRE

SaverOne 2014

$1.15 /

+0.02 (+1.77%)

, EZFL

EzFill

/

+

EzFill (EZFL) announced a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SVRE SaverOne 2014
$1.15 /

+0.02 (+1.77%)

EZFL EzFill
/

+

EZFL EzFill
/

+

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.